About Mininavident
Mininavident is a Healthcare company based in Basel (Switzerland) founded in 2013 by Frank Berlinghoff and Hans-Florian Zeilhofer, and was acquired by Straumann Group in August 2024. A miniaturized navigation system for dental implants is developed. Mininavident has raised $1.42 million across 2 funding rounds from investors including Straumann Group, Nobel Biocare and W&H. Its chief executive, as recorded, is Werner Enz. Its focus areas include Life Sciences, Dental Disorders, Medical Devices and Therapeutic Devices.
Company details
Mininavident is a spin-off from the University Hospital Basel and the University of Applied Sciences and Arts northwestern Switzerland FHNW. They have developed a miniaturised navigation system, which is directly fitted to the surgical hand piece, and which guides the drill in real-time and in 3D to the correct implant position and angle using a ceramic dual-mode-marker and proprietary algorithms. Frank Berlinghoff is the CEO of the company.
- Headquarters Basel, Switzerland
- Founders Frank Berlinghoff, Hans-Florian Zeilhofer
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website mininavident.com
- Acquired by Straumann Group (Aug 2024)
- Total Equity Funding$1.42M (USD)
in 2 rounds
- InvestorsStraumann Group
& 3 more
- Acquired byStraumann Group
(Aug 2024)
Funding Insights of Mininavident
Mininavident has successfully raised a total of $1.42M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.42M
- Total Rounds 2
- First Round $1.42M
(Mar 2015)
- Investors Count 4
All 2 funding rounds of Mininavident with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | Series C | – | Straumann Group | – | |
| Mar 2015 | $1.42M | Series B | – | – |
4 investors in total: 4 institutional.
Investors in Mininavident
Mininavident has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Straumann Group, Nobel Biocare and W&H.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Dental implants and regenerative dentistry products are developed. | 1954 | straumann.com | Basel, Switzerland | |
W&H is recognized for manufacturing high-quality dental equipment. | wh.com | Bürmoos, Austria | ||
Offers banking services including accounts, loans, investments, and advisory for customers. | 1913 | akb.ch | Aarau, Switzerland | |
Implant, prosthetic and regenerative solutions for dental markets | 1952 | nobelbiocare.com | Zurich, Switzerland |
Investor details for Mininavident
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Mininavident
5 people are tracked at Mininavident (4 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Frank Berlinghoff | Co-Founder | Leadership |
Hans-Florian Zeilhofer | Co-Founder | Leadership |
Werner Enz | CEO | Leadership |
Erik Schkommodau | Co-Founder | Leadership |
George Raeber | Member Of The Board Of Directors | Team |
Complete people profiles for Mininavident
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Mininavident
4 dated milestones of Mininavident across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Mininavident is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Series C,.
- Exit Acquired by Straumann Group.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mininavident
Complete news archive for Mininavident
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mininavident
Mininavident was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Mininavident is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Werner Enz is the CEO of Mininavident, as recorded in our data.
Mininavident is a funded company, having raised a total of $1.42M across 2 funding rounds to date. The company's 1st funding round was a Series B of $1.42M, raised on Mar 2015.
Mininavident is a spin-off from the University Hospital Basel and the University of Applied Sciences and Arts northwestern Switzerland FHNW. They have developed a miniaturised navigation system, which is directly fitted to the surgical hand piece, and which guides the drill in real-time and in 3D to the correct implant position and angle using a ceramic dual-mode-marker and proprietary algorithms. Frank Berlinghoff is the CEO of the company.
Mininavident has 4 investors. Key investors include Straumann Group, Nobel Biocare, W&H, and Aargau Cantonal Bank.
Yes. Mininavident was acquired by Straumann Group in August 2024.